Head and neck cancer that has spread to local tissue or nearby lymph nodes
A chance for longer life
ERBITUX with radiation therapy (RT) may offer you the possibility.
ERBITUX with radiation therapy (RT) or RT alone was studied in a clinical study of 424 people with a certain type of locally or regionally advanced head and neck cancer. About half of the people (211) received ERBITUX with RT and the other half (213) were treated with RT alone.
The main goal of this clinical study was to assess the length of time people’s cancer did not grow or spread from where it started to nearby tissues or lymph nodes. An additional goal of the study was to measure how long people survived overall.
Results of the clinical study showed that combining ERBITUX with RT gave more people the opportunity for a longer life compared to RT alone.